Overview

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This is a study that will investigate the safety and efficacy of an investigational drug in Human immunodeficiency virus (HIV) infected patients.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Efavirenz
Lamivudine
Raltegravir Potassium
Tenofovir